DLL3
- 产品详情
- 实验流程
Primary Accession | Q9NYJ7-1 |
---|---|
Species | Human |
Sequence | Ala27-Arg490 |
Purity | > 95% as determined by Bis-Tris PAGE |
Endotoxin Level | Less than 1 EU per µg by the LAL method. |
Biological Activity | Immobilized DLL3, His, Human (Cat.No.: Z03813) at 0.1 µg/ml can bind Anti-DLL3 Antibody. |
Expression System | HEK293 |
Theoretical Molecular Weight | 50.4 kDa |
Formulation | Lyophilized from 0.22 µm filtered solution in PBS, 200 mM Arginine, pH 7.4. |
Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 µg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Storage & Stability | Upon receiving, the lyophilized product remains stable up to 6 months at -20 °C or below as supplied from date of receipt.-80°C for 3 months after reconstitution.Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Target Background | DLL3, a transmembrane protein in the Delta/Serrate/Lag-2 (DSL) family of Notch ligands, inhibits primary neurogenesis and helps divert neurons along specific differentiation pathways. It also contributes to the formation of somite boundaries during paraxial mesoderm segmentation. |
---|
Research Areas
For Research Use Only. Not For Use In Diagnostic Procedures.
Application Protocols
Provided below are standard protocols that you may find useful for product applications.

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.